北京时间5月13日收盘,ZNTL市盈率为-27.58,ZNTL市值为12亿美元

ZNTL简介

ZentalisPharmaceuticals,LLCisaclinical-stagebiopharmaceuticalcompanyfocusedondiscoveringanddevelopingsmallmoleculetherapeuticstargetingfundamentalbiologicalpathwaysofcancers.Ituseitshighlyefficientdrugdiscoveryengine,whichitrefertoasitsIntegratedDiscoveryEngine,toidentifytargetsanddevelopsmallmoleculenewchemicalentities,orNCEs,withpropertiesthatitbelievecouldresultinpotentiallydifferentiatedproductprofiles.Itsdiscoveryenginecombinesitsextensiveexperienceandcapabilitiesacrosscancerbiologyandmedicinalchemistry.